SymBio Pharmaceuticals
4582.TTSE GROWTHPharmaceutical
Major holders (5%+) · 3
| Holder | Stake |
|---|---|
| Evo Fund | 48.93% |
| Cantor Fitzgerald Europe | 7.35% |
| YOSHIDA FUMINORI | 6.35% |
Each holder's own ratio from its most recent large-shareholding report.
Former and minor holders (below 5%) · 2
| Heights Capital Management, Inc. | 4.18% |
| Evolution Capital Management LLC | 0.00% |
Ownership history · 74
| Holder | Ratio | Change |
|---|---|---|
| Evolution Capital Management LLC2025-08-19 · amended | 0.00% | no change |
| Evo Fund2025-08-19 · amended | 49.78% | -1.54pp |
| Evolution Capital Management LLC2025-08-19 · amended | 0.00% | no change |
| Evo Fund2025-08-19 · amended | 51.32% | -0.57pp |
| Evolution Capital Management LLC2025-08-19 · amended | 0.00% | new |
| Evo Fund2025-08-19 · amended | 51.89% | new |
| Cantor Fitzgerald Europe2025-04-16 · amended | 13.68% | +6.24pp |
| Cantor Fitzgerald Europe2025-03-25 | 7.44% | -1.67pp |
| Cantor Fitzgerald Europe2025-02-28 | 9.11% | -1.11pp |
| Cantor Fitzgerald Europe2025-02-17 | 10.22% | -1.11pp |
| Cantor Fitzgerald Europe2025-02-10 · amended | 11.33% | +6.32pp |
| Cantor Fitzgerald Europe2025-01-23 | 5.01% | -1.66pp |
| Cantor Fitzgerald Europe2025-01-16 | 6.67% | new |
| Heights Capital Management, Inc.2024-07-25 · amended | 4.18% | new |
Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.